Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-014892
Filing Date
2022-04-15
Accepted
2022-04-15 17:05:45
Documents
1
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4162
  Complete submission text file 0000899243-22-014892.txt   5675
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Tyagarajan Seshu (Reporting) CIK: 0001923794 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 22830556